San Diego, CA 10/14/2009 2:36:39 AM
Vascular Solutions (VASC), Life Technologies (LIFE) Charts Reviewed, Outlook Offered
Vascular Solutions, Life Technologies are examined from a technical perspective.
Biotechnology stocks Vascular Solutions Inc. (VASC) and Life Technologies Corporation (LIFE) have been reviewed for trade-worthiness at the Small Cap Network's new biotech community page. Each chart poses a different opportunity with different time frames, yet both may offer strong potential movement. The site's analysts add clear suggestions and triggering events with the outlook for each chart.
Life Technologies Corporation shares have found resistance at a key level following a year-long rally from $20 to the current price around $48. LIFE is unlikely to break above resistance, however, unless a handful of other chart events transpire first. Pending profitably, however, may well be the catalyst Life Technologies Corporation needs to start the next bullish leg.
Vascular Solutions Inc. (VASC) started the day out as one of the market's biggest biotech gainers, but the stock faded - rapidly - from its highs. The trading analyst suggests there were more profit-takers waiting in the wings than there were buyers. A specific suggestion for VASC was also added to the overall outlook.
Investors can review the entire outlook for Vascular Solutions, Life Technologies Corporation, and two other biotech stocks by going to: http://www.smallcapnetwork.com/s/.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company's product line consists of five major categories: hemostat (blood clotting) products, extraction (clot removal) catheters, vein products, specialty catheters and access products. Vascular Solutions delivers its proprietary and distributed products to interventional cardiologists, interventional radiologists and vascular surgeons through its direct U.S. sales force and international distributor network.
About Life Technologies
Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.
Forward-Looking Statement: This press release may include or imply "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
SmallCapNetwork.com is not a registered investment advisers or broker/dealer. SmallCapNetwork.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for many of their securities, investing in such securities is highly speculative and carries a high degree of risk.
Contact Information:
Small Cap Network
4653 Carmel Mtn. Rd
Suite 308 #402
San Diego, CA 92130
Email: editor@smallcapnetwork.com
Source: Small Cap Network
